MC
CELG

Muhlenkamp & Co’s Celgene Corp CELG Stock Holding History

Muhlenkamp & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-70,655
Closed -$7.02M – 39
2019
Q3 		$7.02M Buy
70,655
+34
+0% +$3.23K 3.42% 14
2019
Q2 		$6.53M Sell
70,621
-210
-0.3% -$19.9K 3.17% 15
2019
Q1 		$6.68M Buy
+70,831
New +$6.19M 3.17% 17
2018
Q3 		$6.45M Sell
72,116
-377
-0.5% -$33.3K 2.76% 19
2018
Q2 		$5.76M Hold
72,493
– – 2.2% 23
2018
Q1 		$6.47M Buy
72,493
+2,392
+3% +$230K 2.35% 22
2017
Q4 		$7.32M Sell
70,101
-1,354
-2% -$153K 2.16% 20
2017
Q3 		$10.4M Sell
71,455
-963
-1% -$131K 3.28% 13
2017
Q2 		$9.4M Sell
72,418
-75
-0.1% -$9.19K 2.95% 13
2017
Q1 		$9.02M Sell
72,493
-195
-0.3% -$23.3K 2.76% 15
2016
Q4 		$8.41M Sell
72,688
-827
-1% -$92.1K 2.66% 18
2016
Q3 		$7.68M Buy
73,515
+53,706
+271% +$5.81M 2.9% 15
2016
Q2 		$1.95M Buy
+19,809
New +$2.05M 0.76% 31
2015
Q2 		– Sell
-85,540
Closed -$9.86M – 78
2015
Q1 		$9.86M Sell
85,540
-700
-0.8% -$83.6K 2.08% 25
2014
Q4 		$9.65M Sell
86,240
-60,700
-41% -$6.4M 1.93% 24
2014
Q3 		$13.9M Buy
146,940
+2,800
+2% +$253K 2.52% 16
2014
Q2 		$12.4M Sell
144,140
-154,510
-52% -$11.8M 2.18% 18
2014
Q1 		$20.8M Buy
298,650
+3,800
+1% +$301K 3.67% 7
2013
Q4 		$24.9M Buy
294,850
+8,240
+3% +$652K 4.34% 3
2013
Q3 		$22.1M Buy
286,610
+840
+0.3% +$58.9K 4.39% 4
2013
Q2 		$16.7M Buy
+285,770
New +$17.2M 3.48% 9

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Muhlenkamp & Co's CELG Position: Q4 2019 in Review

Muhlenkamp & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 70,655 shares — an estimated $7.02M sold.

Muhlenkamp & Co first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $24.9M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Muhlenkamp & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Muhlenkamp & Co sold 70,655 Celgene Corp shares in Q4 2019, an estimated $7.02M.
  • Muhlenkamp & Co first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Muhlenkamp & Co's Celgene Corp position peaked at $24.9M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Muhlenkamp & Co's 13F filing for Q4 2019, filed 20 Feb 2020.